Loading clinical trials...
Loading clinical trials...
Phase I/II Trial of Lenalidomide in Combination With Vorinostat and Dexamethasone as Therapy in Relapsed or Refractory Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)
Conditions
Interventions
Vorinostat, Lenalidomide
Locations
5
Austria
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Innsbruck, Tyrol, Austria
Krankenhaus der Elisabethinen Linz
Linz, Austria
Krankenhaus der Stadt Linz
Linz, Austria
Universitaetsklinik f. Innere Medizin III
Salzburg, Austria
Hanusch Krankenhaus
Vienna, Austria
Start Date
September 1, 2009
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2012
Last Updated
December 24, 2013
Lead Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions